Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal

CompletedOBSERVATIONAL
Enrollment

842

Participants

Timeline

Start Date

April 30, 2021

Primary Completion Date

March 6, 2024

Study Completion Date

March 6, 2024

Conditions
Asthma
Trial Locations (37)

4575-029

Research Site, Alpendorada

4615-604

Research Site, Vila Cova Da Lixa

3810-437

Research Site, Aradas

3140-022

Research Site, Arazede

4700-395

Research Site, Braga

2750-642

Research Site, Cascais

3030-790

Research Site, Coimbra

7005-389

Research Site, Evora

7005-451

Research Site, Evora

4820-273

Research Site, Fafe

2410-272

Research Site, Leiria

1749-080

Research Site, Lisbon

1769-001

Research Site, Lisbon

1800-192

Research Site, Lisbon

2640-465

Research Site, Mafra

8005-518

Research Site, Montenegro

2780-163

Research Site, Oeiras

3880-225

Research Site, Ovar

2955-050

Research Site, Pinhal Novo

4805-273

Research Site, Ponte

4050-046

Research Site, Porto

4100-203

Research Site, Porto

4450-021

Research Site, Porto

4460-282

Research Site, Porto

2745-862

Research Site, Queluz

2975-326

Research Site, Quinta Do Conde

4870-162

Research Site, Ribeira de Pena

2635-364

Research Site, Rio de Mouro

8800-534

Research Site, Tavira

2300-469

Research Site, Tomar

3460-541

Research Site, Tondela

4900-369

Research Site, Viana do Castelo

4480-807

Research Site, Vila do Conde

2260-400

Research Site, Vila Nova da Barquinha

4400-712

Research Site, Vila Nova de Gaia

5000-557

Research Site, Vila Real

3670-261

Research Site, Vouzela

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Faculdade de Medicina da Universidade do Porto - CINTESIS

UNKNOWN

collaborator

Universidade do Minho - ICVS

UNKNOWN

lead

AstraZeneca

INDUSTRY